Insider Trading › RTRX › Insiders
RTRX
RTRX·Insider activity
—
No end-of-day price on record
RTRX
Insider purchases and sales on the price
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
RTRXS&P 500 (rebased)
Insider BuyInsider SellForm 144 · planned sale
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
No open-market insider purchases or sales of RTRX were filed in the last 180 days. Newest filing Nov 25, 2020 (5 years ago).
Net Insider Buying by Quarter
Shares bought (+) or sold (−) on the open market by RTRX insiders · Form 4 · last two years
No open-market insider buys or sells in the last two years.
On Record
$0Purchases · 180 days
$0Sales · 180 days
188Open-market transactions on record
0Insiders filing · 180 days
Purchases (code P) and sales (code S) of RTRX common stock reported on Form 4, with Form 5 annual catch-ups. Grants, option exercises, gifts and tax withholding are not shown. Dollars are shares × the stated price; a price outside anything the stock traded at that day is withheld (n/c).
Insider Transactions
188 on record · newest trade first
AllPurchasesSalesOfficers & directors
| Insider | Type | Shares | Price | Value | Held after | Traded | Filed | |
|---|---|---|---|---|---|---|---|---|
| Clague LauraChief Financial Officer | Sale | −3,750 | $22.72 | $85K | 19.5Kdirect | Nov 25, 2020 | Nov 25, 2020 | Form 4 ↗ |
| Clague LauraChief Financial Officer | Sale | −3,750 | $23.86 | $89K | 23.2Kdirect | Nov 24, 2020 | Nov 25, 2020 | Form 4 ↗ |
| Clague LauraChief Financial Officer | Sale | −7,500 | $23.98 | $180K | 19.5Kdirect | Nov 16, 2020 | Nov 17, 2020 | Form 4 ↗ |
| REED ELIZABETH ESVP, GC & Corporate Secretary | Sale | −2,500 | $23.98 | $60K | 25.4Kdirect | Nov 16, 2020 | Nov 17, 2020 | Form 4 ↗ |
| ROTE WILLIAM E.Senior Vice President, R&D | Sale | −2,500 | $23.96 | $60K | 24.1Kdirect | Nov 16, 2020 | Nov 17, 2020 | Form 4 ↗ |
| REED ELIZABETH ESVP, GC & Corporate Secretary | Sale | −2,500 | $23.62 | $59K | 27.9Kdirect | Nov 13, 2020 | Nov 13, 2020 | Form 4 ↗ |
| ROTE WILLIAM E.Senior Vice President, R&D | Sale | −2,500 | $23.62 | $59K | 26.6Kdirect | Nov 13, 2020 | Nov 13, 2020 | Form 4 ↗ |
| Clague LauraChief Financial Officer | Sale | −7,500 | $23.61 | $177K | 27.0Kdirect | Nov 13, 2020 | Nov 13, 2020 | Form 4 ↗ |
| ASELAGE STEVEDirector | Sale | −20.6K | $23.00 | $474K | 213.1Kdirect | Nov 6, 2020 | Nov 6, 2020 | Form 4 ↗ |
| ASELAGE STEVEDirector | Sale | −2,500 | $21.26 | $53K | 233.7Kdirect | Nov 5, 2020 | Nov 6, 2020 | Form 4 ↗ |
| Heerma PeterChief Commercial Officer | Sale | −2,188 | $19.35 | $42K | 42.3Kdirect | Oct 5, 2020 | Oct 5, 2020 | Form 4 ↗ |
| Heerma PeterChief Commercial Officer | Sale | −2,188 | $18.90 | $41K | 44.5Kdirect | Oct 2, 2020 | Oct 5, 2020 | Form 4 ↗ |
| ROTE WILLIAM E.Senior Vice President, R&D | Sale | −1,500 | $18.48 | $28K | 24.1Kdirect | Sep 23, 2020 | Sep 23, 2020 | Form 4 ↗ |
| REED ELIZABETH ESVP, GC & Corporate Secretary | Sale | −1,500 | $18.48 | $28K | 25.4Kdirect | Sep 23, 2020 | Sep 23, 2020 | Form 4 ↗ |
| Rosenberg Noah L.Chief Medical Officer | Sale | −750 | $18.48 | $14K | 27.6Kdirect | Sep 23, 2020 | Sep 23, 2020 | Form 4 ↗ |
| Clague LauraChief Financial Officer | Sale | −1,500 | $18.48 | $28K | 19.5Kdirect | Sep 23, 2020 | Sep 23, 2020 | Form 4 ↗ |
| ROTE WILLIAM E.Senior Vice President, R&D | Sale | −1,500 | $18.59 | $28K | 25.6Kdirect | Sep 22, 2020 | Sep 22, 2020 | Form 4 ↗ |
| Rosenberg Noah L.Chief Medical Officer | Sale | −750 | $18.59 | $14K | 28.3Kdirect | Sep 22, 2020 | Sep 22, 2020 | Form 4 ↗ |
| REED ELIZABETH ESVP, GC & Corporate Secretary | Sale | −1,500 | $18.59 | $28K | 26.9Kdirect | Sep 22, 2020 | Sep 22, 2020 | Form 4 ↗ |
| Clague LauraChief Financial Officer | Sale | −1,500 | $18.59 | $28K | 21.0Kdirect | Sep 22, 2020 | Sep 22, 2020 | Form 4 ↗ |
| Dube Eric MChief Executive Officer · Director | Sale | −1,565 | $19.29 | $30K | 94.7Kdirect | Sep 21, 2020 | Sep 22, 2020 | Form 4 ↗ |
| Dube Eric MChief Executive Officer · Director | Sale | −9,240 | $19.28 | $178K | 96.3Kdirect | Sep 21, 2020 | Sep 22, 2020 | Form 4 ↗ |
| ASELAGE STEVEDirector | Sale | −2,500 | $19.68 | $49K | 236.2Kdirect | Aug 5, 2020 | Aug 6, 2020 | Form 4 ↗ |
| Rosenberg Noah L.Chief Medical Officer | Sale | −870 | $20.49 | $18K | 26.1Kdirect | Jul 28, 2020 | Jul 30, 2020 | Form 4 ↗ |
| ASELAGE STEVEDirector | Sale | −10.0K | $20.00 | $200K | 238.7Kdirect | Jun 25, 2020 | Jun 29, 2020 | Form 4 ↗ |
| ASELAGE STEVEDirector | Sale | −3,062 | $15.09 | $46K | 245.7Kdirect | May 14, 2020 | May 14, 2020 | Form 4 ↗ |
| ASELAGE STEVEDirector | Sale | −4,063 | $16.41 | $67K | 248.8Kdirect | May 13, 2020 | May 14, 2020 | Form 4 ↗ |
| ASELAGE STEVEDirector | Sale | −1,000 | $17.16 | $17K | 252.9Kdirect | May 12, 2020 | May 14, 2020 | Form 4 ↗ |
| REED ELIZABETH ESVP, GC & Corporate Secretary | Sale | −527 | $16.98 | $9K | 25.4Kdirect | May 12, 2020 | May 13, 2020 | Form 4 ↗ |
| REED ELIZABETH ESVP, GC & Corporate Secretary | Sale | −525 | $17.16 | $9K | 26.0Kdirect | May 12, 2020 | May 13, 2020 | Form 4 ↗ |
| ROTE WILLIAM E.Senior Vice President, R&D | Sale | −527 | $16.98 | $9K | 23.5Kdirect | May 12, 2020 | May 13, 2020 | Form 4 ↗ |
| ROTE WILLIAM E.Senior Vice President, R&D | Sale | −812 | $17.16 | $14K | 24.0Kdirect | May 12, 2020 | May 13, 2020 | Form 4 ↗ |
| Clague LauraChief Financial Officer | Sale | −527 | $16.98 | $9K | 19.5Kdirect | May 12, 2020 | May 13, 2020 | Form 4 ↗ |
| Clague LauraChief Financial Officer | Sale | −1,250 | $17.16 | $21K | 20.0Kdirect | May 12, 2020 | May 13, 2020 | Form 4 ↗ |
| Rosenberg Noah L.Chief Medical Officer | Sale | −527 | $16.98 | $9K | 26.7Kdirect | May 12, 2020 | May 13, 2020 | Form 4 ↗ |
| REED ELIZABETH ESVP, GC & Corporate Secretary | Sale | −525 | $14.95 | $8K | 26.5Kdirect | May 11, 2020 | May 13, 2020 | Form 4 ↗ |
| ROTE WILLIAM E.Senior Vice President, R&D | Sale | −813 | $14.95 | $12K | 24.8Kdirect | May 11, 2020 | May 13, 2020 | Form 4 ↗ |
| Clague LauraChief Financial Officer | Sale | −1,250 | $14.95 | $19K | 21.3Kdirect | May 11, 2020 | May 13, 2020 | Form 4 ↗ |
| ASELAGE STEVEDirector | Sale | −2,500 | $15.88 | $40K | 253.9Kdirect | May 5, 2020 | May 6, 2020 | Form 4 ↗ |
| ROTE WILLIAM E.Senior Vice President, R&D | Sale | −3,250 | $14.87 | $48K | 25.6Kdirect | Mar 10, 2020 | Mar 12, 2020 | Form 4 ↗ |
| REED ELIZABETH ESVP, GC & Corporate Secretary | Sale | −3,500 | $15.02 | $53K | 27.0Kdirect | Mar 10, 2020 | Mar 12, 2020 | Form 4 ↗ |
| Clague LauraChief Financial Officer | Sale | −4,000 | $15.02 | $60K | 22.5Kdirect | Mar 10, 2020 | Mar 12, 2020 | Form 4 ↗ |
| Rosenberg Noah L.Chief Medical Officer | Sale | −1,790 | $15.36 | $27K | 27.3Kdirect | Mar 5, 2020 | Mar 9, 2020 | Form 4 ↗ |
| ASELAGE STEVEDirector | Sale | −4,359 | $15.36 | $67K | 256.4Kdirect | Mar 5, 2020 | Mar 9, 2020 | Form 4 ↗ |
| ROTE WILLIAM E.Senior Vice President, R&D | Sale | −1,250 | $16.55 | $21K | 25.6Kdirect | Feb 18, 2020 | Feb 19, 2020 | Form 4 ↗ |
| ROTE WILLIAM E.Senior Vice President, R&D | Sale | −1,250 | $16.72 | $21K | 26.9Kdirect | Feb 14, 2020 | Feb 19, 2020 | Form 4 ↗ |
| ASELAGE STEVEDirector | Sale | −2,500 | $16.62 | $42K | 248.5Kdirect | Feb 5, 2020 | Feb 7, 2020 | Form 4 ↗ |
| REED ELIZABETH ESVP, GC & Corporate Secretary | Sale | −750 | $15.14 | $11K | 18.0Kdirect | Jan 8, 2020 | Jan 8, 2020 | Form 4 ↗ |
| Dube Eric MChief Executive Officer · Director | Sale | −3,750 | $15.14 | $57K | 42.5Kdirect | Jan 8, 2020 | Jan 8, 2020 | Form 4 ↗ |
| REED ELIZABETH ESVP, GC & Corporate Secretary | Sale | −750 | $13.94 | $10K | 18.8Kdirect | Jan 7, 2020 | Jan 8, 2020 | Form 4 ↗ |
| Dube Eric MChief Executive Officer · Director | Sale | −3,750 | $13.94 | $52K | 46.3Kdirect | Jan 7, 2020 | Jan 8, 2020 | Form 4 ↗ |
| ASELAGE STEVEDirector | Sale | −5,000 | $13.91 | $70K | 251.0Kdirect | Nov 29, 2019 | Nov 29, 2019 | Form 4 ↗ |
| Rosenberg Noah L.Chief Medical Officer | Sale | −1,250 | $20.07 | $25K | 13.5Kdirect | Jul 31, 2019 | Jul 31, 2019 | Form 4 ↗ |
| Rosenberg Noah L.Chief Medical Officer | Sale | −1,250 | $19.82 | $25K | 14.8Kdirect | Jul 30, 2019 | Jul 31, 2019 | Form 4 ↗ |
| McFarlane Neil F.Chief Operating Officer | Sale | −984 | $18.71 | $18K | 27.0Kdirect | May 16, 2019 | May 16, 2019 | Form 4 ↗ |
| Clague LauraChief Financial Officer | Sale | −1,250 | $18.71 | $23K | 13.5Kdirect | May 16, 2019 | May 16, 2019 | Form 4 ↗ |
| McFarlane Neil F.Chief Operating Officer | Sale | −984 | $17.78 | $17K | 28.0Kdirect | May 15, 2019 | May 16, 2019 | Form 4 ↗ |
| Clague LauraChief Financial Officer | Sale | −1,250 | $17.78 | $22K | 14.8Kdirect | May 15, 2019 | May 16, 2019 | Form 4 ↗ |
| ROTE WILLIAM E.Senior Vice President, R&D | Sale | −812 | $17.76 | $14K | 18.2Kdirect | May 15, 2019 | May 16, 2019 | Form 4 ↗ |
| REED ELIZABETH ESVP, GC & Corporate Secretary | Sale | −525 | $17.71 | $9K | 19.5Kdirect | May 15, 2019 | May 16, 2019 | Form 4 ↗ |
| ASELAGE STEVEDirector | Sale | −1,838 | $17.82 | $33K | 256.0Kdirect | May 15, 2019 | May 16, 2019 | Form 4 ↗ |
| ROTE WILLIAM E.Senior Vice President, R&D | Sale | −813 | $17.78 | $14K | 19.0Kdirect | May 14, 2019 | May 16, 2019 | Form 4 ↗ |
| REED ELIZABETH ESVP, GC & Corporate Secretary | Sale | −525 | $17.75 | $9K | 20.0Kdirect | May 14, 2019 | May 16, 2019 | Form 4 ↗ |
| ASELAGE STEVEDirector | Sale | −1,838 | $17.79 | $33K | 257.8Kdirect | May 14, 2019 | May 16, 2019 | Form 4 ↗ |
| ROTE WILLIAM E.Senior Vice President, R&D | Sale | −1,250 | $21.52 | $27K | 13.8Kdirect | Feb 19, 2019 | Feb 20, 2019 | Form 4 ↗ |
| ROTE WILLIAM E.Senior Vice President, R&D | Sale | −1,250 | $21.44 | $27K | 15.1Kdirect | Feb 15, 2019 | Feb 20, 2019 | Form 4 ↗ |
| REED ELIZABETH ESVP, GC & Corporate Secretary | Sale | −884 | $21.50 | $19K | 14.6Kdirect | Feb 12, 2019 | Feb 13, 2019 | Form 4 ↗ |
| ROTE WILLIAM E.Senior Vice President, R&D | Sale | −992 | $21.50 | $21K | 16.0Kdirect | Feb 12, 2019 | Feb 13, 2019 | Form 4 ↗ |
| Clague LauraChief Financial Officer | Sale | −1,016 | $21.50 | $22K | 10.0Kdirect | Feb 12, 2019 | Feb 13, 2019 | Form 4 ↗ |
| ASELAGE STEVEChief Executive Officer · Director | Sale | −1,065 | $21.50 | $23K | 257.6Kdirect | Feb 12, 2019 | Feb 13, 2019 | Form 4 ↗ |
| REED ELIZABETH ESVP, GC & Corporate Secretary | Sale | −885 | $21.38 | $19K | 15.4Kdirect | Feb 11, 2019 | Feb 13, 2019 | Form 4 ↗ |
| ROTE WILLIAM E.Senior Vice President, R&D | Sale | −993 | $21.38 | $21K | 17.0Kdirect | Feb 11, 2019 | Feb 13, 2019 | Form 4 ↗ |
| Clague LauraChief Financial Officer | Sale | −1,017 | $21.38 | $22K | 11.0Kdirect | Feb 11, 2019 | Feb 13, 2019 | Form 4 ↗ |
| ASELAGE STEVEChief Executive Officer · Director | Sale | −1,065 | $21.38 | $23K | 258.7Kdirect | Feb 11, 2019 | Feb 13, 2019 | Form 4 ↗ |
| REED ELIZABETH ESVP, GC & Corporate Secretary | Sale | −750 | $23.82 | $18K | 16.3Kdirect | Jan 9, 2019 | Jan 9, 2019 | Form 4 ↗ |
| REED ELIZABETH ESVP, GC & Corporate Secretary | Sale | −750 | $24.09 | $18K | 17.1Kdirect | Jan 8, 2019 | Jan 9, 2019 | Form 4 ↗ |
| ASELAGE STEVEChief Executive Officer · Director | Sale | −900 | $22.35 | $20K | 259.8Kdirect | Dec 21, 2018 | Dec 21, 2018 | Form 4 ↗ |
| ASELAGE STEVEChief Executive Officer · Director | Sale | −5,288 | $21.69 | $115K | 260.7Kdirect | Dec 21, 2018 | Dec 21, 2018 | Form 4 ↗ |
| Clague LauraChief Financial Officer | Sale | −900 | $22.34 | $20K | 12.0Kdirect | Dec 21, 2018 | Dec 21, 2018 | Form 4 ↗ |
| Clague LauraChief Financial Officer | Sale | −2,850 | $21.67 | $62K | 12.9Kdirect | Dec 21, 2018 | Dec 21, 2018 | Form 4 ↗ |
| McFarlane Neil F.Chief Operating Officer | Sale | −6,404 | $22.56 | $144K | 29.0Kdirect | Dec 20, 2018 | Dec 21, 2018 | Form 4 ↗ |
| McFarlane Neil F.Chief Operating Officer | Sale | −4,721 | $22.00 | $104K | 35.4Kdirect | Dec 20, 2018 | Dec 21, 2018 | Form 4 ↗ |
| ASELAGE STEVEChief Executive Officer · Director | Sale | −6,188 | $21.97 | $136K | 266.0Kdirect | Dec 20, 2018 | Dec 21, 2018 | Form 4 ↗ |
| Clague LauraChief Financial Officer | Sale | −3,750 | $22.08 | $83K | 15.8Kdirect | Dec 20, 2018 | Dec 21, 2018 | Form 4 ↗ |
| ASELAGE STEVEChief Executive Officer · Director | Sale | −10 | $24.04 | $240 | 251.5Kdirect | Dec 7, 2018 | Dec 7, 2018 | Form 4 ↗ |
| REED ELIZABETH ESVP, GC & Corporate Secretary | Sale | −100 | $24.81 | $2K | 17.8Kdirect | Nov 15, 2018 | Nov 16, 2018 | Form 4 ↗ |
| REED ELIZABETH ESVP, GC & Corporate Secretary | Sale | −100 | $24.77 | $2K | 17.9Kdirect | Nov 15, 2018 | Nov 16, 2018 | Form 4 ↗ |
| REED ELIZABETH ESVP, GC & Corporate Secretary | Sale | −2,300 | $24.29 | $56K | 18.0Kdirect | Nov 15, 2018 | Nov 16, 2018 | Form 4 ↗ |
| ROTE WILLIAM E.Senior Vice President, R&D | Sale | −312 | $24.83 | $8K | 18.0Kdirect | Nov 15, 2018 | Nov 16, 2018 | Form 4 ↗ |
| ROTE WILLIAM E.Senior Vice President, R&D | Sale | −2,188 | $24.25 | $53K | 18.3Kdirect | Nov 15, 2018 | Nov 16, 2018 | Form 4 ↗ |
| Clague LauraChief Financial Officer | Sale | −791 | $24.73 | $20K | 12.0Kdirect | Nov 15, 2018 | Nov 16, 2018 | Form 4 ↗ |
| Clague LauraChief Financial Officer | Sale | −2,959 | $24.20 | $72K | 12.8Kdirect | Nov 15, 2018 | Nov 16, 2018 | Form 4 ↗ |
| ASELAGE STEVEChief Executive Officer · Director | Sale | −1,086 | $24.75 | $27K | 253.3Kdirect | Nov 15, 2018 | Nov 16, 2018 | Form 4 ↗ |
| ASELAGE STEVEChief Executive Officer · Director | Sale | −4,464 | $24.21 | $108K | 254.4Kdirect | Nov 15, 2018 | Nov 16, 2018 | Form 4 ↗ |
| McFarlane Neil F.Chief Operating Officer | Sale | −1,000 | $24.64 | $25K | 28.5Kdirect | Nov 14, 2018 | Nov 16, 2018 | Form 4 ↗ |
| McFarlane Neil F.Chief Operating Officer | Sale | −9,000 | $23.63 | $213K | 29.5Kdirect | Nov 14, 2018 | Nov 16, 2018 | Form 4 ↗ |
| REED ELIZABETH ESVP, GC & Corporate Secretary | Sale | −300 | $24.57 | $7K | 20.3Kdirect | Nov 14, 2018 | Nov 16, 2018 | Form 4 ↗ |
| REED ELIZABETH ESVP, GC & Corporate Secretary | Sale | −2,200 | $23.62 | $52K | 20.6Kdirect | Nov 14, 2018 | Nov 16, 2018 | Form 4 ↗ |
| ROTE WILLIAM E.Senior Vice President, R&D | Sale | −300 | $24.57 | $7K | 20.5Kdirect | Nov 14, 2018 | Nov 16, 2018 | Form 4 ↗ |
| ROTE WILLIAM E.Senior Vice President, R&D | Sale | −2,200 | $23.62 | $52K | 20.8Kdirect | Nov 14, 2018 | Nov 16, 2018 | Form 4 ↗ |
| Clague LauraChief Financial Officer | Sale | −400 | $24.54 | $10K | 15.8Kdirect | Nov 14, 2018 | Nov 16, 2018 | Form 4 ↗ |
| Clague LauraChief Financial Officer | Sale | −3,350 | $23.63 | $79K | 16.2Kdirect | Nov 14, 2018 | Nov 16, 2018 | Form 4 ↗ |
| ASELAGE STEVEChief Executive Officer · Director | Sale | −600 | $24.58 | $15K | 258.8Kdirect | Nov 14, 2018 | Nov 16, 2018 | Form 4 ↗ |
| ASELAGE STEVEChief Executive Officer · Director | Sale | −4,950 | $23.63 | $117K | 259.4Kdirect | Nov 14, 2018 | Nov 16, 2018 | Form 4 ↗ |
| ASELAGE STEVEChief Executive Officer · Director | Sale | −12.0K | $32.00 | $384K | 245.9Kdirect | Aug 31, 2018 | Aug 31, 2018 | Form 4 ↗ |
| ROTE WILLIAM E.Senior Vice President, R&D | Sale | −1,034 | $21.50 | $22K | 11.2Kdirect | Feb 14, 2018 | Feb 16, 2018 | Form 4 ↗ |
| REED ELIZABETH ESVP, GC & Corporate Secretary | Sale | −942 | $24.04 | $23K | 9,058direct | Jan 5, 2018 | Jan 8, 2018 | Form 4 ↗ |
| McFarlane Neil F.Chief Operating Officer | Sale | −1,378 | $22.50 | $31K | 13.6Kdirect | Aug 16, 2017 | Aug 17, 2017 | Form 4 ↗ |
| ASELAGE STEVEChief Executive Officer · Director | Purchase | −5,000 | $17.85 | $89K | 245.6Kdirect | Jun 14, 2017 | Jun 14, 2017 | Form 4 ↗ |
| ASELAGE STEVEChief Executive Officer · Director | Sale | −3,200 | $21.30 | $68K | 240.6Kdirect | Nov 22, 2016 | Nov 23, 2016 | Form 4 ↗ |
| ASELAGE STEVEChief Executive Officer · Director | Sale | −5,000 | $21.00 | $105K | 243.8Kdirect | Nov 21, 2016 | Nov 23, 2016 | Form 4 ↗ |
| Shih AlvinEVP of Research & Development | Sale | −8,750 | $16.24 | $142K | 158.3Kdirect | Sep 1, 2016 | Sep 2, 2016 | Form 4 ↗ |
| Shih AlvinEVP of Research & Development | Sale | −8,750 | $17.75 | $155K | 167.1Kdirect | Jun 1, 2016 | Jun 2, 2016 | Form 4 ↗ |
| Meckler Jeffrey ADirector | Purchase | +5,000 | $15.31 | $77K | 52.0Kdirect | Mar 4, 2016 | Mar 7, 2016 | Form 4 ↗ |
| Meckler Jeffrey ADirector | Purchase | +10.0K | $14.45 | $145K | 47.0Kdirect | Mar 3, 2016 | Mar 3, 2016 | Form 4 ↗ |
| Shih AlvinEVP of Research & Development | Sale | −8,750 | $14.35 | $126K | 175.8Kdirect | Mar 1, 2016 | Mar 1, 2016 | Form 4 ↗ |
| Shih AlvinEVP of Research & Development | Sale | −8,750 | $20.83 | $182K | 184.6Kdirect | Dec 9, 2015 | Dec 10, 2015 | Form 4 ↗ |
| ASELAGE STEVEChief Executive Officer · Director | Sale | −30.0K | $18.72 | $562K | 308.8Kdirect | Nov 10, 2015 | Nov 12, 2015 | Form 4 ↗ |
| ASELAGE STEVEChief Executive Officer · Director | Sale | −30.0K | $18.77 | $563K | 338.8Kdirect | Nov 9, 2015 | Nov 12, 2015 | Form 4 ↗ |
| VALEUR JENSEN MARGARET EGeneral Counsel | Sale | −5,336 | $21.12 | $113K | 50.0Kdirect | Nov 2, 2015 | Nov 4, 2015 | Form 4 ↗ |
| VALEUR JENSEN MARGARET EGeneral Counsel | Sale | −44.7K | $20.38 | $910K | 55.3Kdirect | Nov 2, 2015 | Nov 4, 2015 | Form 4 ↗ |
| Shih AlvinEVP of Research & Development | Sale | −1,129 | $21.61 | $24K | 193.3Kdirect | Oct 6, 2015 | Oct 8, 2015 | Form 4 ↗ |
| Shih AlvinEVP of Research & Development | Sale | −2,823 | $20.45 | $58K | 194.5Kdirect | Oct 6, 2015 | Oct 8, 2015 | Form 4 ↗ |
| Shih AlvinEVP of Research & Development | Sale | −4,798 | $19.58 | $94K | 197.3Kdirect | Oct 6, 2015 | Oct 8, 2015 | Form 4 ↗ |
| Shih AlvinEVP of Research & Development | Sale | −27.9K | $32.70 | $913K | 202.1Kdirect | Jun 26, 2015 | Jun 30, 2015 | Form 4 ↗ |
| Plotkin HoracioChief Medical Officer | Sale | −2,100 | $10.07 | $21K | 91.8Kdirect | Dec 12, 2014 | Dec 16, 2014 | Form 4 ↗ |
| Meckler Jeffrey ADirector | Purchase | +15.0K | $8.60 | $129K | 35.0Kdirect | Nov 25, 2014 | Nov 25, 2014 | Form 4 ↗ |
| Shkreli Martin | Sale | −252.8K | $8.41 | $2.1M | 1.8Mdirect | Nov 21, 2014 | Nov 24, 2014 | Form 4 ↗ |
| Richardson Steven GaryDirector | Purchase | +6,100 | $8.38 | $51K | 129.2Kdirect | Nov 21, 2014 | Nov 24, 2014 | Form 4 ↗ |
| ASELAGE STEVEChief Executive Officer · Director | Purchase | +8,700 | $8.50 | $74K | 371.8Kdirect | Nov 21, 2014 | Nov 21, 2014 | Form 4 ↗ |
| Shkreli Martin | Sale | −134.4K | $8.23 | $1.1M | 2.0Mdirect | Nov 20, 2014 | Nov 24, 2014 | Form 4 ↗ |
| ASELAGE STEVEChief Executive Officer · Director | Purchase | +1,300 | $8.20 | $11K | 363.1Kdirect | Nov 20, 2014 | Nov 21, 2014 | Form 4 ↗ |
| Shkreli Martin | Sale | −329.8K | $8.54 | $2.8M | 2.2Mdirect | Nov 19, 2014 | Nov 24, 2014 | Form 4 ↗ |
| Golding Cornelius EDirector | Purchase | +2,000 | $9.00 | $18K | 25.0Kdirect | Nov 19, 2014 | Nov 19, 2014 | Form 4 ↗ |
| Shkreli Martin | Sale | −255.0K | $9.19 | $2.3M | 2.5Mdirect | Nov 18, 2014 | Nov 24, 2014 | Form 4 ↗ |
| Shkreli Martin | Sale | −100.0K | $9.41 | $941K | 2.7Mdirect | Nov 17, 2014 | Nov 24, 2014 | Form 4 ↗ |
| Plotkin HoracioChief Medical Officer | Sale | −8,333 | $9.43 | $79K | 93.9Kdirect | Nov 17, 2014 | Nov 19, 2014 | Form 4 ↗ |
| Shkreli Martin | Sale | −100.0K | $10.23 | $1.0M | 2.8Mdirect | Nov 14, 2014 | Nov 24, 2014 | Form 4 ↗ |
| Shkreli MartinChief Executive Officer · Director · 10% owner | Sale | −300.0K | $0.01 | $3K | 2.7Mdirect | Oct 1, 2014 | Oct 9, 2014 | Form 4 ↗ |
| Shkreli MartinChief Executive Officer · Director · 10% owner | Purchase | +25.0K | $8.11 | $203K | 3.0Mdirect | Oct 1, 2014 | Oct 9, 2014 | Form 4 ↗ |
| Shkreli MartinChief Executive Officer · Director · 10% owner | Purchase | +4,000 | $9.42 | $38K | 2.9Mdirect | Sep 30, 2014 | Oct 2, 2014 | Form 4 ↗ |
| Shkreli MartinChief Executive Officer · Director · 10% owner | Purchase | +35.0K | $10.82 | $379K | 2.9Mdirect | Sep 22, 2014 | Sep 23, 2014 | Form 4 ↗ |
| Shkreli MartinChief Executive Officer · Director · 10% owner | Purchase | +18.0K | $11.78 | $212K | 2.9Mdirect | Sep 19, 2014 | Sep 23, 2014 | Form 4 ↗ |
| Shkreli MartinChief Executive Officer · Director · 10% owner | Purchase | +6,000 | $11.46 | $69K | 2.9Mdirect | Sep 17, 2014 | Sep 18, 2014 | Form 4 ↗ |
| Shkreli MartinChief Executive Officer · Director · 10% owner | Purchase | +7,500 | $10.69 | $80K | 2.9Mdirect | Sep 16, 2014 | Sep 16, 2014 | Form 4 ↗ |
| Paley JeffreyDirector | Sale | −20.0K | $12.28 | $246K | 51.7Kdirect | Aug 14, 2014 | Aug 18, 2014 | Form 4 ↗ |
| Shkreli MartinChief Executive Officer · Director · 10% owner | Sale | −292.4K | $15.14 | $4.4M | 2.9Mdirect | May 30, 2014 | Jun 3, 2014 | Form 4 ↗ |
| Shkreli MartinChief Executive Officer · Director · 10% owner | Purchase | +8,000 | $19.64 | $157K | 3.0Mdirect | Apr 4, 2014 | Apr 7, 2014 | Form 4 ↗ |
| Shkreli MartinChief Executive Officer · Director · 10% owner | Purchase | +22.5K | $22.60 | $509K | 3.0Mdirect | Apr 3, 2014 | Apr 4, 2014 | Form 4 ↗ |
| Shkreli MartinChief Executive Officer · Director · 10% owner | Purchase | +10.8K | $22.28 | $241K | 3.0Mdirect | Apr 2, 2014 | Apr 3, 2014 | Form 4 ↗ |
| Shkreli MartinChief Executive Officer · Director · 10% owner | Purchase | +4,000 | $17.61 | $70K | 2.9Mdirect | Mar 24, 2014 | Mar 27, 2014 | Form 4 ↗ |
| Shkreli MartinChief Executive Officer · Director · 10% owner | Purchase | +5,000 | $17.97 | $90K | 2.9Mdirect | Mar 20, 2014 | Mar 21, 2014 | Form 4 ↗ |
| Shkreli MartinChief Executive Officer · Director · 10% owner | Purchase | +3,500 | $18.44 | $65K | 2.9Mdirect | Mar 19, 2014 | Mar 20, 2014 | Form 4 ↗ |
| Shkreli MartinChief Executive Officer · Director · 10% owner | Purchase | +4,000 | $17.36 | $69K | 2.9Mdirect | Mar 14, 2014 | Mar 17, 2014 | Form 4 ↗ |
| Shkreli MartinChief Executive Officer · Director · 10% owner | Purchase | +25.9K | $19.47 | $504K | 2.9Mdirect | Mar 11, 2014 | Mar 12, 2014 | Form 4 ↗ |
| Shkreli MartinChief Executive Officer · Director · 10% owner | Purchase | +10.7K | $19.32 | $207K | 2.9Mdirect | Mar 10, 2014 | Mar 11, 2014 | Form 4 ↗ |
| Shkreli MartinChief Executive Officer · Director · 10% owner | Purchase | +2,498 | $18.26 | $46K | 2.9Mdirect | Mar 7, 2014 | Mar 10, 2014 | Form 4 ↗ |
| Shkreli MartinChief Executive Officer · Director · 10% owner | Purchase | +1,560 | $18.93 | $30K | 2.9Mdirect | Mar 6, 2014 | Mar 10, 2014 | Form 4 ↗ |
| Shkreli MartinChief Executive Officer · Director · 10% owner | Purchase | +4,000 | $18.48 | $74K | 2.9Mdirect | Mar 5, 2014 | Mar 6, 2014 | Form 4 ↗ |
| Shkreli MartinChief Executive Officer · Director · 10% owner | Purchase | +43.0K | $18.67 | $803K | 2.9Mdirect | Feb 28, 2014 | Mar 3, 2014 | Form 4 ↗ |
| Shkreli MartinChief Executive Officer · Director · 10% owner | Purchase | +100 | $17.20 | $2K | 2.8Mdirect | Feb 21, 2014 | Mar 3, 2014 | Form 4 ↗ |
| Shkreli MartinChief Executive Officer · Director · 10% owner | Purchase | +1,600 | $17.56 | $28K | 2.8Mdirect | Feb 21, 2014 | Feb 25, 2014 | Form 4 ↗ |
| Shkreli MartinChief Executive Officer · Director · 10% owner | Purchase | +3,500 | $14.60 | $51K | 2.8Mdirect | Feb 14, 2014 | Feb 19, 2014 | Form 4 ↗ |
| Shkreli MartinChief Executive Officer · Director · 10% owner | Purchase | +2,000 | $9.92 | $20K | 2.8Mdirect | Feb 6, 2014 | Feb 7, 2014 | Form 4 ↗ |
| Shkreli MartinChief Executive Officer · Director · 10% owner | Purchase | +8,000 | $10.84 | $87K | 2.8Mdirect | Jan 14, 2014 | Jan 15, 2014 | Form 4 ↗ |
| Shkreli MartinChief Executive Officer · Director · 10% owner | Purchase | +150.0K | $7.00 | $1.1M | 2.8Mdirect | Dec 31, 2013 | Jan 2, 2014 | Form 4 ↗ |
| Golding Cornelius EDirector | Purchase | +3,000 | $7.50 | $23K | 3,000direct | Dec 24, 2013 | Dec 27, 2013 | Form 4 ↗ |
| Shkreli MartinChief Executive Officer · Director · 10% owner | Purchase | +100 | $8.11 | $811 | 2.7Mdirect | Dec 9, 2013 | Dec 10, 2013 | Form 4 ↗ |
| Shkreli MartinChief Executive Officer · Director · 10% owner | Purchase | +100 | $8.30 | $830 | 2.7Mdirect | Dec 6, 2013 | Dec 10, 2013 | Form 4 ↗ |
| Shkreli MartinChief Executive Officer · Director · 10% owner | Purchase | +150 | $6.81 | $1K | 2.7Mdirect | Nov 26, 2013 | Dec 2, 2013 | Form 4 ↗ |
| Shkreli MartinChief Executive Officer · Director · 10% owner | Purchase | +300 | $6.06 | $2K | 2.7Mdirect | Nov 22, 2013 | Dec 2, 2013 | Form 4 ↗ |
| Richardson Steven GaryDirector | Purchase | +2,900 | $6.90 | $20K | 102.1Kdirect | Nov 5, 2013 | Nov 8, 2013 | Form 4 ↗ |
| Shkreli MartinChief Executive Officer · Director · 10% owner | Purchase Amended | +5,556 | $4.50 | $25K | 2.7Mdirect | Sep 12, 2013 | Jan 14, 2014 | Form 4 ↗ |
| Shkreli MartinChief Executive Officer · Director · 10% owner | Purchase | +11.1K | $4.50 | $50K | 2.7Mdirect | Sep 12, 2013 | Sep 16, 2013 | Form 4 ↗ |
| Shkreli MartinChief Executive Officer · Director · 10% owner | Purchase | +1,100 | $6.02 | $7K | 2.7Mdirect | Aug 22, 2013 | Aug 23, 2013 | Form 4 ↗ |
| Shkreli MartinChief Executive Officer · Director · 10% owner | Purchase | +2,800 | $6.08 | $17K | 2.7Mdirect | Aug 21, 2013 | Aug 23, 2013 | Form 4 ↗ |
| Richardson Steven GaryDirector | Purchase | +1,110 | $4.50 | $5K | 99.2Kdirect | Aug 15, 2013 | Dec 30, 2013 | Form 4 ↗ |
| ASELAGE STEVEDirector | Purchase | +556 | $4.50 | $3K | 261.8Kdirect | Aug 15, 2013 | Dec 27, 2013 | Form 4 ↗ |
| Plotkin HoracioChief Medical Officer | Purchase | +2,200 | $4.50 | $10K | 2,200direct | Aug 15, 2013 | Aug 23, 2013 | Form 4 ↗ |
| PANOFF MARC LChief Financial Officer | Purchase | +1,100 | $4.50 | $5K | 121.1Kdirect | Aug 15, 2013 | Aug 20, 2013 | Form 4 ↗ |
| Shkreli MartinChief Executive Officer · Director · 10% owner | Purchase | +400 | $4.70 | $2K | 2.7Mdirect | Mar 11, 2013 | Mar 12, 2013 | Form 4 ↗ |
| Shkreli MartinChief Executive Officer · Director · 10% owner | Purchase | +100 | $4.25 | $425 | 2.7Mdirect | Mar 6, 2013 | Mar 12, 2013 | Form 4 ↗ |
| Shkreli MartinChief Executive Officer · Director · 10% owner | Purchase | +1,000 | $4.43 | $4K | 2.7Mdirect | Mar 4, 2013 | Mar 6, 2013 | Form 4 ↗ |
| Shkreli MartinChief Executive Officer · Director · 10% owner | Purchase | +1,120 | $4.16 | $5K | 2.7Mdirect | Feb 20, 2013 | Feb 21, 2013 | Form 4 ↗ |
| Shkreli MartinChief Executive Officer · Director · 10% owner | Purchase | +120.0K | $3.00 | $360K | 2.7Mdirect | Feb 14, 2013 | Feb 19, 2013 | Form 4 ↗ |
| Shkreli MartinChief Executive Officer · Director · 10% owner | Purchase | +1,400 | $3.57 | $5K | 2.5Mdirect | Feb 12, 2013 | Feb 13, 2013 | Form 4 ↗ |
| Shkreli MartinChief Executive Officer · Director · 10% owner | Purchase | +100 | $3.55 | $355 | 2.5Mdirect | Dec 26, 2012 | Dec 28, 2012 | Form 4 ↗ |
| Shkreli MartinChief Executive Officer · Director · 10% owner | Purchase | +100 | $7.69 | $769 | 2.5Mdirect | Dec 17, 2012 | Dec 28, 2012 | Form 4 ↗ |
Source: SEC EDGAR Form 4 and Form 5 filings, SEC's quarterly bulk dataset through Jun 30, 2026, and KeyVex's half-hourly read of new filings since. Every row links its filing. Amendments are marked. Nothing here is a recommendation. All insider activity, market-wide →